This CEO Is Using Alpaca DNA To Fight Inflammation & A Lot More! Scinai Immunotherapeutics $SCNI

This CEO Is Using Alpaca DNA To Fight Inflammation & A Lot
More! CEO Scinai… Nasdaq $SCNI Guest: Mr. Amir Reichman Title
& Company: CEO Scinai Immunotherapeutics Ticker: SCNI Website
: https://www.scinai.com/ Bio: Mr. Amir Reichman was appointed as
Scinai’s CEO in 2021.


Born and educated in Israel, Mr. Reichman most recently served as
Head of Global Vaccines Engineering Core Technologies and Asset
Management at GSK Vaccines headquarters in Belgium. Prior to his
role in global vaccines engineering, he served as Senior Director
Global GSK Vaccines Supply Chain. Mr. Reichman joined GSK in 2015
after its acquisition of Novartis Vaccines. At Novartis Vaccines,
he held various leadership roles of increasing responsibility in
its Global Vaccines Supply Chain Management organization located
in Holly Springs, NC, USA.


In 2003, Mr. Reichman’s academic work at Ben-Gurion University of
the Negev contributed to the founding of NeuroDerm Ltd., an
Israeli company focused on transdermal drug delivery systems that
was acquired by Mitsubishi Tanabe Pharma in 2017 for $1.1B. He
was NeuroDerm’s first employee and served as the company’s Chief
Engineer and Senior Scientist until his departure in 2009.


Mr. Reichman earned an M.Sc. in Biotechnology Engineering from
the Ben-Gurion University of the Negev in Israel, and an MBA in
Finance and Health Care Management from the Wharton School of the
University of Pennsylvania, USA.”